Works matching IS 02692813 AND DT 2017 AND VI 45 AND IP 4

Results: 23

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 542, doi. 10.1111/apt.13880
By:
- Doecke, J. D.;
- Hartnell, F.;
- Bampton, P.;
- Bell, S.;
- Mahy, G.;
- Grover, Z.;
- Lewindon, P.;
- Jones, L. V.;
- Sewell, K.;
- Krishnaprasad, K.;
- Prosser, R.;
- Marr, D.;
- Fischer, J.;
- R Thomas, G.;
- Tehan, J. V.;
- Ding, N. S.;
- Cooke, S. E.;
- Moss, K.;
- Sechi, A.;
- De Cruz, P.
Publication type:
Article
Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 572, doi. 10.1111/apt.13881
By:
- Zamani, M.;
- Shokri‐Shirvani, J.;
- Zamani, V.
Publication type:
Article
Editorial: direct-acting anti-virals - not the be-all and end-all in HIV/ HCV co-infection.
Published in:
2017
By:
- Bulteel, N.;
- Leen, C.
Publication type:
Editorial
The course of achalasia one to four decades after initial treatment.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 553, doi. 10.1111/apt.13888
By:
- Sawas, T.;
- Ravi, K.;
- Geno, D. M.;
- Enders, F.;
- Pierce, K.;
- Wigle, D.;
- Katzka, D. A.
Publication type:
Article
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 510, doi. 10.1111/apt.13889
By:
- Petta, S.;
- Ciminnisi, S.;
- Di Marco, V.;
- Cabibi, D.;
- Cammà, C.;
- Licata, A.;
- Marchesini, G.;
- Craxì, A.
Publication type:
Article
Letter: need to re-evaluate non-invasive markers for staging fibrosis in chronic delta hepatitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 574, doi. 10.1111/apt.13890
By:
- Huang, R.;
- Yan, X.;
- Jia, B.;
- Wang, G.;
- Liu, Y.;
- Wu, C.
Publication type:
Article
Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century.
Published in:
2017
By:
- Patel, D.
Publication type:
Editorial
Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 519, doi. 10.1111/apt.13893
By:
- Angelison, L.;
- Almer, S.;
- Eriksson, A.;
- Karling, P.;
- Fagerberg, U.;
- Halfvarson, J.;
- Thörn, M.;
- Björk, J.;
- Hindorf, U.;
- Löfberg, R.;
- Bajor, A.;
- Hjortswang, H.;
- Hammarlund, P.;
- Grip, O.;
- Torp, J.;
- Marsal, J.;
- Hertervig, E.
Publication type:
Article
Systematic review: recurrent autoimmune liver diseases after liver transplantation.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 485, doi. 10.1111/apt.13894
By:
- Montano‐Loza, A. J.;
- Bhanji, R. A.;
- Wasilenko, S.;
- Mason, A. L.
Publication type:
Article
Effects of nucleoside analogue prescription for hepatitis B on the incidence of liver cancer in Hong Kong: a territory-wide ecological study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 501, doi. 10.1111/apt.13895
By:
- Seto, W.‐K.;
- Lau, E. H. Y.;
- Wu, J. T. K.;
- Hung, I. F. N.;
- Leung, W. K.;
- Cheung, K.‐S.;
- Fung, J.;
- Lai, C.‐L.;
- Yuen, M.‐F.
Publication type:
Article
Editorial: volatile organic compounds in irritable bowel syndrome - technology for an accurate and reliable point-of-care test?
Published in:
2017
By:
- Sood, R.;
- Ford, A. C.
Publication type:
Editorial
The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 533, doi. 10.1111/apt.13897
By:
- Carrat, F.;
- Seksik, P.;
- Colombel, J.‐F.;
- Peyrin‐Biroulet, L.;
- Beaugerie, L.;
- Colombel, Jean‐Frédéric;
- Cosnes, Jacques;
- Gendre, Jean‐Pierre;
- Lémann, Marc;
- Hébuterne, Xavier;
- Cortot, Antoine;
- Bouhnik, Yoram;
- Laharie, David;
- Dupas, Jean Louis;
- Flourié, Bernard;
- Lerebours, Eric;
- Beaugerie, Laurent;
- Peyrin‐Biroulet, Laurent;
- Allez, Matthieu;
- Messing, Bernard
Publication type:
Article
Letter: need to re-evaluate non-invasive markers for staging fibrosis in chronic delta hepatitis - authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 575, doi. 10.1111/apt.13898
By:
- Takyar, V.;
- Koh, C.
Publication type:
Article
Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 576, doi. 10.1111/apt.13900
By:
- Kountouras, J.;
- Polyzos, S. A.;
- Kapetanakis, N.;
- Katsinelos, P.;
- Nikolopoulos, P.;
- Stogianni, A.;
- Kazakos, E.;
- Zeglinas, C.;
- Stefanidis, E.;
- Romiopoulos, I.;
- Tzivras, D.;
- Boziki, M.;
- Dardiotis, E.;
- Deretzi, G.
Publication type:
Article
Editorial: treating the liver to treat the kidney in non-alcoholic steatohepatitis.
Published in:
2017
By:
- Gifford, F. J.;
- Dhaun, N.
Publication type:
Editorial
Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome.
Published in:
2017
By:
- Bennet, S. M. P.;
- Törnblom, H.
Publication type:
Editorial
Editorial: direct acting antivirals - not the be-all and end-all in HIV/ HCV co-infection. Authors' reply.
Published in:
2017
By:
- Schwabl, P.;
- Mandorfer, M.;
- Reiberger, T.
Publication type:
Editorial
Corrigendum.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 579, doi. 10.1111/apt.13908
Publication type:
Article
Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 573, doi. 10.1111/apt.13909
By:
- Chen, P.‐Y.;
- Wu, M.‐S.;
- Liou, J.‐M.
Publication type:
Article
Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century - authors' reply.
Published in:
2017
By:
- Simmons, O.;
- Fetzer, D. T.;
- Yokoo, T.;
- Marrero, J. A.;
- Yopp, A.;
- Parikh, N.;
- Browning, T.;
- Singal, A. G.
Publication type:
Editorial
Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia - authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 577, doi. 10.1111/apt.13911
By:
- Ahn, J. S.;
- Sinn, D. H.;
- Son, H. J.;
- Gwak, G.‐Y.
Publication type:
Article
Editorial: treating the liver to treat the kidney in non-alcoholic steatohepatitis - authors' reply.
Published in:
2017
By:
- Vilar‐Gomez, E.;
- Chalasani, N.
Publication type:
Editorial
Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome. Authors' reply.
Published in:
2017
By:
- Xu, X. J.;
- Yao, S. K.
Publication type:
Editorial